TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
Meijer A,
Diepstraten F,
Langer T,
Broer L,
Domingo I,
Clemens E,
Uitterlinden A,
de Vries A,
van Grotel M,
Vermeij W,
Ozinga R,
Binder H,
Byrne J,
van Dulmen-den Broeder E,
Garre MK,
Grabow D,
Kaatsch P,
Kaiser M,
Kenborg L,
Winther J,
Rechnitzer C,
Hasle H,
Kepak T,
Kepakova K,
Tissing W,
van der Kooi A,
Kremer L,
Kruseova J,
Pluijm SMF,
Kuehni C,
van der Pal H,
Parfitt R,
Spix C,
Tillmanns A,
Deuster D,
Matulat P,
Calaminus G,
Hoetink AE,
Elsner S,
Gebauer J,
Haupt R,
Lackner H,
Blattmann C,
Neggers S,
Rassekh S,
Wright G,
Brooks B,
Nagtegaal A,
Drögemöller B,
Ross C,
Bhavsar A,
am Zehnhoff-Dinnesen A,
Carleton B,
Zolk O,
van den Heuvel-Eibrink M,
PanCareLIFE Consortium,
The CPNDS Consortium July 2021Publication
NPJ Precis Oncol